The role of lymphangiogenesis and angiogenesis in tumor metastasis

Cellular Oncology

Volumn 39, Issue 5, 2016, Pages 397-410

  Paduch, Roman ^a,b  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Angiogenesis; Lymph nodes; Lymphangiogenesis; Metastasis

Indexed keywords

ANGIOGENESIS; BLOOD VESSEL; CAPILLARY DENSITY; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HYPOXIA; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; METASTASIS; PRIORITY JOURNAL; REVIEW; TISSUE PRESSURE; TUMOR CELL; TUMOR HYPOXIA; ANIMAL; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR INVASION;

ANIMALS; HUMANS; LYMPHANGIOGENESIS; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84964556389     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-016-0281-9     Document Type: Review

References (145)

1. Z. Cao, B. Shang, G. Zhang, L. Miele, F.H. Sarkar, Z. Wang, Q. Zhou, Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochim. Biophys. Acta 1836, 273–286 (2013)
2. Y. You, H. Li, X. Qin, Y. Zhang, W. Song, Y. Ran, F. Gao, Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients—a short report. Cell. Oncol. 38, 485–491 (2015)
3. S. Wan, Y. Liu, Y. Weng, W. Wang, W. Ren, C. Fei, Y. Chen, Z. Zhang, T. Wang, J. Wang, Y. Jiang, L. Zhou, T. He, Y. Zhang, BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells. Cell. Oncol. 37, 363–375 (2014)
4. S.A. Stacker, M.E. Baldwin, M.G. Achen, The role of tumor lymphangiogenesis in metastasic spread. FASEB J. 16, 922–934 (2002)
5. A. Khosravi, S. Shahrabi, M. Shahjahani, N. Saki, The bone marrow metastasis niche in retinoblastoma. Cell. Oncol. 38, 253–263 (2015)
6. M.S. Pepper, Lymphangiogenesis and tumor metastasis: myth or reality? Clin. Cancer Res. 7, 462–468 (2001)
7. M.S. Pepper, J.-C. Tille, R. Nisato, M. Skobe, Lymphangiogenesis and tumor metastasis. Cell Tissue Res. 314, 167–177 (2003)
8. M. Andrade, A. Jacomo, Anatomy of the Human Lymphatic System, in Cancer Metastasis and the Lymphovascular System. Basis for Rational Therapy, ed. by S.P.L. Leong (Springer Science + Business Media, LCC, New York, 2007), pp. 55–77
9. W. Thiele, J.P. Sleeman, Tumor-induced lymphangiogenesis: a target for cancer therapy? J. Biotechnol. 124, 224–241 (2006)
10. J.S. Reis-Filho, F.C. Schmitt, Lymphangiogenesis in tumors: what do we know? Microsc. Res. Tech. 60, 171–180 (2003)
11. N.E. Tobler, M. Detmar, Tumor and lymph node lymphangiogensesis – impact on cancer metastasis. J. Leukoc. Biol. 80, 691–696 (2006)
12. I. Van der Auwera, Y. Cao, J.C. Tille, M.S. Pepper, D.G. Jackson, S.B. Fox, A.L. Harris, L.Y. Dirix, P.B. Vermeulen, First international consensus on the methodology of lymphangiogenesis quantification in solid human tumors. Br. J. Cancer 95, 1611–1625 (2006)
13. M.A. Swartz, M. Skobe, Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc. Res. Tech. 55, 92–99 (2001)
14. S.B. Seidelmann, J.K. Lighthouse, D.M. Greif, Development and pathologies of the arterial wall. Cell. Mol. Life Sci. 71, 1977–1999 (2014)
15. S. Szala, M. Jarosz, Nowotworowe naczynia krwionośne. Postepy Hig. Med. Dosw. 65, 437–446 (2011)
16. X.-F. Sun, H. Zhang, Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas. Mol. Cancer 5, 20 pages (2006)
17. S. Ran, L. Volk, K. Hall, M.J. Flister, Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology 17, 229–251 (2010)
18. H. Pflicke, M.L. Sixt, Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206, 2925–2935 (2009)
19. A. Ålgars, M. Karikoski, G.G. Yegutkin, P. Stoitzner, J. Niemelä, M. Salmi, S. Jalkanen, Different role of CD73 in leukocyte trafficking via blood and lymph vessels. Blood 117, 4387–4393 (2011)
20. M. Wu, H.B. Frieboes, S.R. McDougall, M.A.J. Chaplain, V. Cristini, J. Lowengrub, The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J. Theor. Biol. 320, 131–151 (2013)
21. G. Azzali, On the transendothelial passage of tumor cell from extravasal matrix into the lumen of absorbing lymphatic vessel. Microvasc. Res. 72, 74–85 (2006)
22. M.G. Achen, B.K. McColl, S.A. Stacker, Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7, 121–127 (2005)
23. M. Bockhorn, R.K. Jain, L.L. Munn, Active or passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol. 8, 444–448 (2007)
24. M.D. Hale, J.D. Hayden, H.I. Grabsch, Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response. Cell. Oncol. 36, 95–112 (2013)
25. D. Yao, C. Dai, S. Peng, Mechanism of the mesenchymal–epithelial transition and its relationship with metastatic tumor formation. Mol. Cancer Res. 9, 1608–1620 (2011)
26. S. Lamouille, J. Xu, R. Derynck, Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196 (2014)
27. R. Kalluri, R.A. Weinberg, The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420–1428 (2009)
28. M. Zeisberg, J.S. Duffield, Resolved: EMT produces fibroblasts in the kidney. J. Am. Soc. Nephrol. 21, 1247–1253 (2010)
29. J.J. Christiansen, A.K. Rajasekaran, Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66, 8319–8326 (2006)
30. H.A. Smith, Y. Kang, The metastasis-promoting roles of tumor-associated immune cells. J. Mol. Med. 91, 411–429 (2013)
31. A. Stockinger, A. Eger, J. Wolf, H. Beug, R. Foisner, E-cadherin regulates cell growth by modulating proliferationdependent beta-catenin transcriptional activity. J. Cell Biol. 154, 1185–1196 (2001)
32. J. Banyard, D.R. Bielenberg, The role of EMT and MET in cancer dissemination. Connect. Tissue Res. 56, 403–413 (2015)
33. H.G. Kang, J.M. Jenabi, J. Zhang, N. Keshelava, H. Shimada, W.A. May, T. Ng, C.P. Reynolds, T.J. Triche, P.H.B. Sorensen, E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 67, 3094–3105 (2007)
34. P. Reddy, L. Liu, C. Ren, P. Lindgren, K. Boman, Y. Shen, E. Lundin, U. Ottander, M. Rytinki, K. Liu, Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells. Mol. Endocrinol. 19, 2564–2578 (2005)
35. A. Wells, C. Yates, C.R. Shepard, E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastasis seeding of disseminated carcinomas. Clin. Exp. Metastasis 25, 621–628 (2008)
36. L. Ding, Z. Zhang, D. Shang, J. Cheng, H. Yuan, Y. Wu, X. Song, H. Jiang, α-Smooth muscle actin-positive myofibroblasts, In association with epithelial–mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma. J. Oral Pathol. Med. 43, 335–343 (2014)
37. D.G. Jackson, R. Prevo, S. Clasper, S. Banerji, LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 22, 317–321 (2001)
38. J. Massague, TGF-beta in cancer. Cell 134, 215–230 (2008)
39. C. Zhou, J. Liu, Y. Tang, X. Liang, Inflammation linking EMT and cancer stem cells. Oral Oncol. 48, 1068–1075 (2012)
40. F.A. Malik, A.J. Sanders, W.G. Jiang, KAI-1/CD82, The molecule and clinical implication in cancer and cancer metastasis. Histol. Histopathol. 24, 519–530 (2009)
41. L. Zhou, L. Yu, S. Wu, Z. Feng, W. Song, X. Gong, Clinicopathological significance of KAI1expression and epithelial-mesenchymal transition in non-small cell lung cancer. World J. Surg. Oncol. 13, 234–241 (2015)
42. J.H. Tsai, J. Yang, Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 27, 2192–2206 (2013)
43. J. Banyard, I. Chung, M. Migliozzi, D.T. Phan, A.M. Wilson, B.R. Zetter, D.R. Bielenberg, Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer. BMC Cancer 14, Article No. 387 (2014)
44. J. Banyard, I. Chung, A.M. Wilson, G. Vetter, A. Le Bechec, D.R. Bielenberg, B.R. Zetter, Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model. Sci. Rep. 3, Article No. 3151 (2013)
45. O.H. Ocana, R. Corcoles, A. Fabra, G. Moreno-Bueno, H. Acloque, S. Vega, A. Barrallo-Gimeno, A. Cano, M.A. Nieto, Metastasis colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709–724 (2012)
46. S.Y. Wong, R.O. Hynes, Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5, 812–817 (2006)
47. H. Luo, G. Tu, Z. Liu, M. Liu, Cancer-associated fibroblasts: a multifaceted driver of breastcancer progression. Cancer Lett. 361, 155–163 (2015)
48. P. Lu, V.M. Weaver, Z. Werb, The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395–406 (2012)
49. M. Aumailley, The laminin family. Cell Adhes. Migr. 7, 48–55 (2013)
50. Y.Z. Lima, A.P. Southa, Tumour-stroma crosstalk in the development of squamous cell carcinoma. Int. J. Biochem. Cell Biol. 53, 450–458 (2014)
51. M.D. Shoulders, R.T. Raines, Collagen structure and stability. Annu. Rev. Biochem. 78, 929–958 (2009)
52. N. Ilan, M. Elkin, I. Vlodavsky, Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int. J. Biochem. Cell Biol. 38, 2018–2039 (2006)
53. K. Kessenbrock, V. Plaks, Z. Werb, Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52–67 (2010)
54. N.A. Bhowmick, E.G. Neilson, H.L. Moses, Stromal fibroblasts in cancer initiation and progression. Nature 432, 332–337 (2004)
55. A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, R.A. Weinberg, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005)
56. M. Quante, S.P. Tu, H. Tomita, T. Gonda, S.S.W. Wang, S. Takashi, G.H. Baik, W. Shibata, B. Diprete, K.S. Betz, R. Friedman, A. Varro, B. Tycko, T.C. Wang, Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 19, 257–272 (2011)
57. N.G. Singer, A.I. Caplan, Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6, 457–478 (2011)
58. P. Kamarajan, Y. Kapila, An altered fibronectin matrix induces anoikis of humansquamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK. Apoptosis 12, 2221–2231 (2007)
59. C. Kainz, P. Kohlberger, C. Tempfer, G. Sliutz, G. Gitsch, A. Reinthaller, G. Breitenecker, Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur. J. Cancer 31A, 1706–1709 (1995)
60. N.J. Nasser, Heparanase involvement in physiology and disease. Cell. Mol. Life Sci. 65, 1706–1715 (2008)
61. R. Stauder, W. Eisterer, J. Thaler, U. Günthert, CD44 variant isoforms in non-Hodgkin’s lymphoma: a new independent prognostic factor. Blood 85, 2885–2899 (1995)
62. J.D. Mott, Z. Werb, Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558–564 (2004)
63. G.E. Davis, D.R. Senger, Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 97, 1093–1107 (2005)
64. M.L. Iruela-Arispe, G.J. Beitel, Tubulogenesis. Development 140, 2851–2855 (2013)
65. C.J. Avraamides, B. Garmy-Susini, J.A. Varner, Integrins in angiogenesis and lymphangiogenesis. Nat. Rev. Cancer 8, 604–617 (2008)
66. X.Z. Huang, J.F. Wu, R. Ferrando, J.H. Lee, Y.L. Wang, R.V. Farese Jr., D. Sheppard, Fatal bilateral chylothorax in mice lacking the integrin α9β1. Mol. Cell. Biol. 20, 5208–5215 (2000)
67. M. Wu, Y. Du, Y. Liu, Y. He, C. Yang, W. Wang, F. Gao, Low molecular weight hyaluronan induces lymphangiogenesis through LYVE-1-mediated signaling pathways. PLoS ONE 9, e92857 (2014)
68. C. Danussi, P. Spessotto, A. Petrucco, B. Wassermann, P. Sabatelli, M. Montesi, R. Doliana, G.M. Bressan, A. Colombatti, Emilin1 deficiency causes structural and functional defects of lymphatic vasculature. Mol. Cell. Biol. 28, 4026–4039 (2008)
69. S. Ingvarsen, A. Porse, C. Erpicum, L. Maertens, H.J. Jürgensen, D.H. Madsen, M.C. Melander, H. Gårdsvoll, G. Høyer-Hansen, A. Noel, K. Holmbeck, L.H. Engelholm, N. Behrendt, Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP. Impact on lymphangiogenesis. J. Biol. Chem. 288, 10195–10204 (2013)
70. Q. Wu, X. Li, H. Yang, C. Lu, J. You, Z. Zhang, Extracellular matrix protein 1 is correlated to carcinogenesis and lymphatic metastasis of human gastric cancer. World J. Surg. Oncol. 12, 132–139 (2014)
71. B.C. Dobner, A.I. Riechardt, A.M. Joussen, S. Englert, N.E. Bechrakis, Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis. Acta Ophthalmol. 90, e638–e644 (2012)
72. V. Montana, H. Sontheimer, Bradykinin promotes the chemotactic invasion of primary brain tumors. J. Neurosci. 31, 4858–4867 (2011)
73. M. Langheinrich, V. Schellerer, K. Oeckl, M. Stürzl, E. Naschberger, R. Croner, Molecular mechanisms of lymphatic metastasis. Colorectal Cancer Book 1, 285–298 (2011)
74. M.C. Langheinrich, V. Schellerer, A. Perrakis, C. Lohmüller, C. Schildberg, E. Naschberger, M. Stürzl, W. Hohenberger, R.S. Croner, Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract. Int. J. Clin. Exp. Pathol. 5, 614–623 (2012)
75. Y. Morita, K. Hata, M. Nakanishi, T. Omata, N. Morita, Y. Yura, R. Nishimura, T. Yoneda, Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma. Clin. Exp. Metastasis 32, 739–753 (2015)
76. L.-C. Du, X.-C. Chen, D. Wang, Y.-J. Wen, C.-T. Wang, X.-M. Wang, B. Kan, Y.-Q. Wei, X. Zhao, VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma. Reprod. Biol. Endocrinol. 12, 14–24 (2014)
77. I. Gisterek, R. Matkowski, J. Koźlak, D. Duś, A. Lacko, J. Szelachowska, J. Kornafel, Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer - 10 years follow-up analysis. Anticancer Res. 27, 2797–2802 (2007)
78. R.A. Mohammed, A. Green, S. El-Shikh, E.C. Paish, I.O. Ellis, S.G. Martin, Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br. J. Cancer 96, 1092–1100 (2007)
79. Y.C. Zhao, X.J. Ni, M.H. Wang, X.M. Zha, Y. Zhao, S. Wang, Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients. Med. Oncol. 29, 2594–2600 (2012)
80. Y. He, T. Karpanen, K. Alitalo, Role of lymphangiogenic factors in tumor metastasis. Biochim. Biophys. Acta 1654, 3–12 (2004)
81. Y. He, K. Kozaki, T. Karpanen, K. Koshikawa, S. Yla-Herttuala, T. Takahashi, K. Alitalo, Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94, 819–825 (2002)
82. G.G. Van den Eynden, I. Van der Auwera, S.J. Van Laere, X.B. Trinh, C.G. Colpaert, P. van Dam, L.Y. Dirix, P.B. Vermeulen, E.A. Van Marck, Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. J. Pathol. 213, 56–64 (2007)
83. M. Esposito, Y. Kang, Targeting tumor–stromal interactions in bone metastasis. Pharmacol. Ther. 141, 222–233 (2014)
84. F.G. Gomes, F. Nedel, A.M. Alves, J.E. Nör, S.B.C. Tarquinio, Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/environmental signaling mechanisms. Life Sci. 92, 101–107 (2013)
85. N. Wakisaka, Y. Hasegawa, S. Yoshimoto, K. Miura, A. Shiotani, J. Yokoyama, M. Sugasawa, M. Moriyama-Kita, K. Endo, T. Yoshizaki, Primary tumor-secreted lymphangiogenic factors induce pre-metastatic lymphvascular niche formation at sentinel lymph nodes in oral squamous cell carcinoma. PLoS ONE 10, e0144056 (2015)
86. S.L. Schlereth, S. Iden, M. Mescher, B.R. Ksander, J.J. Bosch, C. Cursiefen, L.M. Heindl, A novel model of metastatic conjunctival melanoma in immune-competent mice. Invest. Ophthalmol. Vis. Sci. 56, 5965–5973 (2015)
87. T. Duong, P. Koopman, M. Francois, Tumor lymphangiogenesis as a potential therapeutic target. J. Oncol. Article ID 204946, 23 pages (2012)
88. S. Hirakawa, From tumor lymphangiogenesis to lymphvascular niche. Cancer Sci. 100, 983–989 (2009)
89. K. Vazquez-Santillan, J. Melendez-Zajgla, L. Jimenez-Hernandez, G. Martínez-Ruiz, V. Maldonado, NF-κB signaling in cancer stem cells: a promising therapeutic target? Cell. Oncol. 38, 327–339 (2015)
90. J. Wilting, M. Papoutsi, K. Buttler, J. Becker, Embrionic Development of the Lymphovascular System and Tumor Lymphangiogenesis, in Cancer Metastasis and the Lymphovascular System. Basis for Rational Therapy, ed. by S.P.L. Leong (Springer Science + Business Media, LCC, New York, 2007), pp. 17–24
91. T. Li, J. Yang, Q. Zhou, Y. He, Molecular regulation of lymphangiogenesis in development and tumor microenvironment. Cancer Microenviron 5, 249–260 (2012)
92. Z. Lokmic, E.S. Ng, M. Burton, E.G. Stanley, A.J. Penington, A.G. Elefanty, Isolation of human lymphatic endothelial cells by multi-parameter fluorescence-activated cell sorting. J. Vis. Exp. 99, e52691 (2015)
93. G.L. Semenza, Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene 32, 4057–4063 (2013)
94. J. Zhan, Y. Li, J. Yu, Y. Zhao, W. Cao, J. Ma, X. Sun, L. Sun, H. Qian, W. Zhu, W. Xu, Culture medium of bone marrow-derived human mesenchymal stem cells effects lymphatic endothelial cells and tumor lymph vessel formation. Oncol. Lett. 9, 1221–1226 (2015)
95. H. Ding, J. Cai, M. Mao, Y. Fang, Z. Huang, J. Jia, T. Li, L. Xu, J. Wang, J. Zhou, Q. Yang, Z. Wang, Tumor-associated macrophages induce lymphangiogenesis in cervical cancer via interaction with tumor cells. APMIS 122, 1059–1069 (2014)
96. R.-C. Ji, Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell. Mol. Life Sci. 69, 897–914 (2012)
97. M.-X. Da, Z. Wu, H.-W. Tian, Tumor lymphangiogenesis and lymphangiogenesis growth factors. Arch. Med. Res. 39, 365–372 (2008)
98. M.S. Kluger, O.R. Colegio, Lymphangiogenesis linked to VEGF-C from tumor-associated macrophages: Accomplices to metastasis by cutaneous squamous cell carcinoma. J. Invest. Dermatol. 131, 17–19 (2011)
99. C. Scavelli, A. Vacca, G. Di Pietro, F. Dammacco, D. Ribatti, Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 18, 1054–1058 (2004)
100. E. Sundlisæter, A. Dicko, P.Ø. Sakariassen, K. Sondenaa, P.Ø. Enger, R. Bjerkvig, Lymphangiogenesis in colorectal cancer – prognostic and therapeutic aspects. Int. J. Cancer 121, 1401–1409 (2007)
101. S. Amatschek, E. Kriehuber, W. Bauer, B. Reininger, P. Meraner, A. Wolpl, N. Schwifer, C. Haslinger, G. Stingl, D. Maurer, Blood and lymphatic endothelial cell-specyfic differentiation programs are stringently controlled by the tissue environment. Blood 109, 4777–4785 (2007)
102. L. Esak, N.B. Pandey, A.S. Popel, Cross talk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment. Expert Rev. Mol. Med. 17, 18 pages (2015)
103. S.D. Nathanson, Preclinical Models of Regional Lymph Node Tumor Metastasis, in Cancer Metastasis and the Lymphovascular System. Basis for Rational Therapy, ed. by S.P.L. Leong (Springer Science + Business Media, LCC, New York, 2007), pp. 129–156
104. C.P. Ng, C.-L.E. Helm, M.A. Swartz, Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc. Res. 68, 258–264 (2004)
105. S. Eccles, L. Paon, J. Sleeman, Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms. Clin. Exp. Metastasis 24, 619–636 (2007)
106. R. Clarijs, D.J. Ruiter, R.M.W. de Waal, Lymphangiogenesis in malignant tumours: does it occur? J. Pathol. 193, 143–146 (2001)
107. D. Massi, Ö. Gököz, The biological significance of lymphangiogenesis in human tumors. Diagn. Histopathol. 16, 295–305 (2010)
108. V. Mumprecht, M. Detmar, Lymphangiogenesis and cancer metastasis. J. Cell. Mol. Med. 13, 1405–1416 (2009)
109. R.-C. Ji, Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 25, 677–694 (2006)
110. D.G. Jackson, Lymphatic Markers, Tumour Lymphangiogenesis and Lymph Node Metastasis, in Cancer Metastasis and the Lymphovascular System. Basis for Rational Therapy, ed. by S.P.L. Leong (Springer Science + Business Media, LCC, New York, 2007), pp. 39–53
111. J.D. White, P.W. Hewett, D. Kosuge, T. McCulloch, B.C. Enholm, J. Carmichael, J.C. Murray, Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res. 62, 1669–1675 (2002)
112. S. El-Gendi, M. Abdel-Hadi, Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters. J. Egypt. Natl. Canc. Inst. 21, 139–149 (2009)
113. K. Matsumoto, Y. Nakayama, Y. Inoue, N. Minagawa, T. Katsuki, K. Shibao, Y. Tsurudome, K. Hirata, N. Nagata, H. Itoh, Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis. Colon Rectum 50, 308–314 (2007)
114. J. Wang, Y. Guo, B. Wang, J. Bi, K. Li, X. Liang, H. Chu, H. Jiang, Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Mol. Biol. Rep. 39, 11153–11165 (2012)
115. J. Wang, K. Li, B. Wang, J. Bi, Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature. Mol. Biol. Rep. 39, 5331–5338 (2012)
116. I. Pastushenko, P.B. Vermeulen, F.J. Carapeto, G. Van den Eynden, A. Rutten, M. Ara, L.Y. Dirix, S. Van Laere, Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis. Br. J. Dermatol. 170, 66–77 (2014)
117. S. Yang, H. Cheng, J. Cai, L. Cai, J. Zhang, Z. Wang, PlGF expression in pre-invasive and invasive lesions of uterine cervix is associated with angiogenesis and lymphangiogenesis. APMIS 117, 831–838 (2009)
118. M. Nagahashi, S. Ramachandran, O.M. Rashid, K. Takabe, Lymphangiogenesis: a new player in cancer progression. World J. Gastroenterol. 28, 4003–4012 (2010)
119. M. Mohammadi, P. Chena, Effect of microvascular distribution and its density on interstitial fluid pressure in solid tumors: a computational model. Microvasc. Res. 101, 26–32 (2015)
120. A.S. Narang, S. Varia, Role of tumor vascular architecture in drug delivery. Adv. Drug Deliv. Rev. 63, 640–658 (2011)
121. S.J. Lunt, T.M.K. Kalliomaki, A. Brown, V.X. Yang, M. Milosevic, R.P. Hill, Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer 8, 2–15 (2008)
122. X. Zhao, B. Sun, Y. Liu, D. Zhang, Z. Liu, X. Zhao, Q. Gu, H. Ch, X. Dong, N. Che, J. An, Y. Zheng, T. Liu, Linearly patterned programmed cell necrosis induced by chronic hypoxia plays a role in melanoma angiogenesis. J. Cancer 7, 22–31 (2016)
123. J.J. Park, S.J. Hwang, J.-H. Park, H.-J. Lee, Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway. Cell. Oncol. 38, 111–118 (2015)
124. J.-Y. Park, H.-J. Jung, I. Seo, B.K. Jha, S.-I. Suh, M.-H. Suh, W.-K. Baek, Translational suppression of HIF-1α by miconazole through the mTOR signaling pathway. Cell. Oncol. 37, 269–279 (2014)
125. R.-C. Ji, Hypoxia and lymphangiogenesis in tumor microenvironment. Cancer Lett. 346, 6–16 (2014)
126. T. Kuwai, Y. Kitadai, S. Tanaka, S. Onogawa, N. Matsutani, E. Kaio, M. Ito, K. Chayama, Expression of hypoxia-inducible factor-1α is associated with tumor vascularization in human colorectal carcinoma. Int. J. Cancer 105, 176–181 (2003)
127. L. Huang, Z. Zhang, S. Zhang, J. Ren, R. Zhang, H. Zeng, Q. Li, G. Wu, Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway. Int. J. Mol. Med. 27, 407–415 (2011)
128. C. Cursiefen, L. Chen, L.P. Borges, D. Jackson, J. Cao, C. Radziejewski, P.A. D’Amore, M.R. Dana, S.J. Wiegand, J.W. Streilein, VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040–1050 (2004)
129. J.C. Zampell, A. Yan, T. Avraham, S. Daluvoy, E.S. Weitman, B.J. Mehrara, HIF-1α coordinates lymphangiogenesis during wound healing and in response to inflammation. FASEB J. 26, 1027–1039 (2012)
130. Y. Liao, W. Lu, Q. Che, T. Yang, H. Qiu, H. Zhang, X. He, J. Wang, M. Qiu, Y. Zou, W. Gu, X. Wan, SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level. PLoS ONE 9, e99907 (2014)
131. M.A.A. Al-Rawi, W.G. Jiang, Lymphangiogenesis and cancer metastasis. Front. Biosci. 16, 723–739 (2011)
132. C. Wissmann, M. Detmar, Pathways targeting tumor lymphangiogenesis. Clin. Cancer Res. 12, 6865–6868 (2006)
133. S. Fukunaga, K. Maeda, E. Noda, T. Inoue, K. Wada, K. Hirakawa, Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis In colorectal cancer. Oncology 71, 204–211 (2006)
134. M. Haseba, T. Tsuji, H. Yano, H. Komatsu, S. Hidaka, T. Sawai, T. Yasutake, T. Nakagoe, Y. Tagawa, Expressions of vascular endothelial growth factor (VEGF)-D and VEGF receptor-3 in colorectal cancer: relationship to lymph node metastasis. Acta Med. Nagasaki 47, 155–160 (2002)
135. X.-B. Kang, Q.-A. Lü, W. Cui, M.-W. Zhang, L.-M. Xie, Correlations of expressions of VEGF-C, Flt-4 and survivin with metastasis of lymph nodes in colorectal carcinoma tissues. Chin. J. Cancer Prev. Treat. 14, 1232–1234 (2007)
136. J.H. Mou, X.C. Yan, Z.P. Li, D. Wang, G.J. Duan, D.B. Xiang, H.L. Xiao, Q.H. Zhang, Characteristic and clinicopathological significance of lymphangiogenesis in colorectal cancer. Zhonghua bing li xue za zhi Chin. J. Pathol. 34, 348–352 (2005)
137. R.B. Rebhun, A.J. Lazar, I.J. Fidler, J.E. Gershenwald, Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin. Exp. Metastasis 25, 191–199 (2008)
138. M.G. Achen, G.B. Mann, S.A. Stacker, Targeting lymphangiogenesis to prevent tumour metastasis. Br. J. Cancer 94, 1355–1360 (2006)
139. S. Hirakawa, L.F. Brown, S. Kodama, K. Paavonen, K. Alitalo, M. Dietmar, VEGF-C induces lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109, 1010–1017 (2007)
140. H.-J. Han, H.-B. Kim, J. Cha, J.-K. Lee, H. Youn, J.-K. Chung, S. Kim, K.-S. Soh, Primo Vessel as a novel cancer cell migration path from testis with nanoparticle-labeled and GFP expressing cancer cells. J. Acupunct. Meridian. Stud. 6, 298–305 (2013)
141. M.A. Islam, S.D. Thomas, K.J. Sedoris, S.P. Slone, H. Alatassi, D.M. Miller, Tumor-associated primo vascular system is derived from xenograft, not host. Exp. Mol. Pathol. 94, 84–90 (2013)
142. J. Lim, S. Lee, Z. Su, H.B. Kim, J.S. Yoo, K.-S. Soh, S. Kim, Y.H. Ryu, Primo vascular system accompanying a blood vessel from tumor tissue and a method to distinguish It from the blood or the lymph system. Evid. Bas. Complement. Altern. Med. Article ID 949245, 6 pages (2013)
143. K.A. Kang, C. Maldonado, G. Perez-Aradia, P. An, K.-S. Soh, Primo Vascular System and Its Potential Role in Cancer Metastasis, in Oxygen Transport to Tissue XXXV, ed. by S. Van Huffel, G. Naulaers, A. Caicedo, D.F. Bruley, D.K. Harrison, vol. 789 (Springer Science + Business Media, LCC, New York, 2013), pp. 289–296. book part IV
144. J.S. Yoo, H.B. Kim, N. Won, J. Bang, S. Kim, S. Ahn, B.-C. Lee, K.-S. Soh, Evidence for an additional metastasis route: in vivo imaging of cancer cells in the primo-vascular system around tumors and organs. Mol. Imaging Biol. 13, 471–480 (2011)
145. N.F. Cheville (ed.), Ultrastructural Pathology the Comparative Cellular Basis of Disease, 2nd edn. (Wiley-Blackwell, Ames, 2009), pp. 1–973